US 2016.0022590A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2016/0022590 A1 ODID (43) Pub. Date: Jan. 28, 2016

(54) COMPOSITIONS AND METHODS FOR A613 L/4439 (2006.01) REDUCING OVERDOSE A619/20 (2006.01) A613 L/485 (2006.01) (71) Applicant: Isa ODIDI, Toronto (CA) A63L/366 (2006.01) (52) U.S. Cl. (72) Inventor: Isa ODIDI, Toronto (CA) CPC ...... A61K 9/2846 (2013.01); A61 K3I/485 (2013.01); A61 K31/192 (2013.01); A61 K (21) Appl. No.: 14/790,101 3I/5513 (2013.01); A61K3I/515 (2013.01); (22) Filed: Jul. 2, 2015 A6 IK3I/167 (2013.01); A61 K3I/366 (2013.01); A61 K3I/4458 (2013.01); A61 K Related U.S. Application Dat 31/135 (2013.01); A6IK3I/197 (2013.01); e pplication Uata A6 IK3I/4439 (2013.01); A61 K9/2813 (63) Continuation of application No. PCT/CA2015/ (2013.01); A61 K9/282 (2013.01); A61 K 050567, filed on Jun. 19, 2015. 9/2013 (2013.01); A61 K9/2018 (2013.01); A6IK9/2054 (2013.01); A61 K9/2059 (60) Pgyal 1 applicationaroplication No.No 62/O24,940,94U, filedTlled on Jul.Ju (2013.01); A61 K9/2027 (2013.01);s A61 K 9/2031 (2013.01); A61K 9/4891 (2013.01); Publication Classification A61K 9/4866 (2013.01); A61 K9/4858 (2013.01); A61 K9/485 (2013.01) (51) Int. C. A6 IK 9/28 (2006.01) (57) ABSTRACT A6 IK3I/92 (2006.01) A 6LX3/553 (2006.01) Drug delivery formulations, uses thereof and methods of A6 IK3I/55 (2006.01) making same are provided in order to reduce the potential for A6 IK3I/67 (2006.01) abuse, misuse or improper administration of an addictive A6 IK9/48 (2006.01) Substance or any active Substance and to prevent, reduce, A6 IK3I/4458 (2006.01) inhibit, or delay purposeful or accidental overdose of an A6 IK3I/35 (2006.01) active Substance by ingesting too many dosage forms at once, A 6LX3/97 (2006.01) for example. Patent Application Publication Jan. 28, 2016 Sheet 1 of 35 US 2016/0022590 A1

1000 9.00 –0- 60mg/520ml 8.00 -- 90mg/520ml 7.00 -A - 100mg/320ml 6.00 -- 120mg/520ml -- 60mg/500ml PH 5.00 -o- 100mg/500ml 4.00 -- 120mg/500ml - 180mg/500ml 3.00 - 200mg/500ml 2.00 -e- 240mg/500ml 1.00 0 1 2 3 4 5 6 7 8 9 10 20 30 4050 60 Time (Min)

FIG. 1 Patent Application Publication Jan. 28, 2016 Sheet 2 of 35 US 2016/0022590 A1

09070|69/G7£.Z|0

00’0 Patent Application Publication Jan. 28, 2016 Sheet 3 of 35 US 2016/0022590 A1

10.00 900 8.00 700 -0- 20mg/520ml 6.00 pH 5.00 -a- 40mg/520ml 400 5.00

1.00 0.00 0 1 2 3 4 5 6 7 8 9 10 20 30 40 50 60 Time (Min)

FIG. 3 Patent Application Publication Jan. 28, 2016 Sheet 4 of 35 US 2016/0022590 A1

h S. s C h Cld s S o OC

:

X

o o ed so ed o o o o o o o Co O Ced Ced Ced C Ced Ced Co Co O O o o ox N o s N can s Co r v Patent Application Publication Jan. 28, 2016 Sheet 5 of 35 US 2016/0022590 A1

(UN)Qu|| G(5)|–|

00"| 00’0 08090,7OZ0 Patent Application Publication Jan. 28, 2016 Sheet 6 of 35 US 2016/0022590 A1

On C. C.

N.S N.S CN5 q q. v. r n n C O Co CD CD CD C C C, CD CD C9

O od

co o

- O S ce CD seF LL

O on

O S S S S 3 3 S 3 do N. de ned on o Patent Application Publication Jan. 28, 2016 Sheet 7 of 35 US 2016/0022590 A1

(HO)6N6u10OG :fiu-96OO|+ £0000

0 9

09

07 (uN)9uull

OZ Patent Application Publication Jan. 28, 2016 Sheet 8 of 35 US 2016/0022590 A1

08

09

00,9 00? 00"| Patent Application Publication Jan. 28, 2016 Sheet 9 of 35 US 2016/0022590 A1

10.00

9.00

8.00 7.00 –0 - 10mg (11.13 actual) 6.00 -H 50mg (50.11 mg actual) pH 5.00 - A - 80mg (81.68mg actual)

4.00

3.00

2.00

1.00

0.00 Time (Min) FIG. 9 Patent Application Publication Jan. 28, 2016 Sheet 10 of 35 US 2016/0022590 A1

0909Off09 (UN)Qu]]| Patent Application Publication Jan. 28, 2016 Sheet 11 of 35 US 2016/0022590 A1

? C/ O E O s

C 2

o CD :

s Patent Application Publication Jan. 28, 2016 Sheet 12 of 35 US 2016/0022590 A1

d e d e C - C th d C9 S e t s s c s c E O o

.9 C C C9 : Patent Application Publication Jan. 28, 2016 Sheet 13 of 35 US 2016/0022590 A1

-O-1 toblet -- 2 toblets - 3 toblets -0-4 toblets -H 5 toblets - A - 6 toblets

0 1 2 3 4 5 6 7 8 9 10 11 12 131415 1617 1819 2021222324 Time (Hr) FIG. 13A

100 90 80 70 -- 10 tablets - A - 20 toblets is 60 -H 40 toblets -- 60 toblets Ž 50 --80 tablets -- 100 tablets 40 30 20 10 Patent Application Publication Jan. 28, 2016 Sheet 14 of 35 US 2016/0022590 A1

S Š S

S Šiš : S S Š

O O O O O ŠS Patent Application Publication Jan. 28, 2016 Sheet 15 of 35 US 2016/0022590 A1

100

80 d 60 -E-1 tablet -A-2 tablets a -- 5 toblets - 4 tablets 2 -- 5 tablets -0- 6 tablets s 40

20

O Time (Hr) FIG. 14A

-E-10 toblet - A - 20 tablets 2 -e- 40 toblets - 60 toblets Ž s

Time (Hr) FIG. 14B Patent Application Publication Jan. 28, 2016 Sheet 16 of 35 US 2016/0022590 A1

FIG. 14C FIG. 14D

FIG. 14E F.G. 14F

FIG. 14G FIG. 14H Patent Application Publication Jan. 28, 2016 Sheet 17 of 35 US 2016/0022590 A1

100 90 80 70 -E-1 tablet a 60 - A - 2 tablets s -E-5 tablets Ž 50 - 4 tablets S 40 -- 5 tablets

100

80 -- 10 tablet - A - 20 toblets -- 40 toblets - 60 toblets Patent Application Publication Jan. 28, 2016 Sheet 18 of 35 US 2016/0022590 A1

FIG.15D

FIG.15F

FIG.15H

FIG.15

FIG.15K Patent Application Publication Jan. 28, 2016 Sheet 19 of 35 US 2016/0022590 A1

100

SZ 20 Toblets (ENTOSSÍ0% Ø 50 Toblets (Il 40 Toblets

Omin §– ?.Š? Time Hr FIG. 15L

10 toblets

20 tablets

50 toblets

40 tablets

50 toblets ZZZZZZZZZZZZZZZZZZZZZ,cº? NBZENZ 100 toblets Patent Application Publication Jan. 28, 2016 Sheet 20 of 35 US 2016/0022590 A1

CENTOSS|(1% N |---- |||zz 201 (100 tob §